Evidence map›Paper›PMID 32267102›Full record

Trial reportAnnals of clinical and translational neurology2020

Impact of simultaneous subthalamic and nigral stimulation on dysphagia in Parkinson's disease.

Christina Pflug, Julie C Nienstedt, Alessandro Gulberti, Frank Müller, Eik Vettorazzi, Jana-Christiane Koseki, Almut Niessen, Till Flügel, Ute Hidding, Carsten Buhmann and 5 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Annals of clinical and translational neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Swallow sound acoustics: a cost-effective objective tool for swallowing assessment in individuals with neurogenic dysphagia.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Christina PflugDepartment of Voice, Speech and Hearing Disorders, Center for Clinical Neurosciences, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.ORCID 0000-0001-8374-431X
Julie C NienstedtDepartment of Voice, Speech and Hearing Disorders, Center for Clinical Neurosciences, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Alessandro GulbertiDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Frank MüllerDepartment of Voice, Speech and Hearing Disorders, Center for Clinical Neurosciences, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Eik VettorazziInstitute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Jana-Christiane KosekiDepartment of Voice, Speech and Hearing Disorders, Center for Clinical Neurosciences, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Almut NiessenDepartment of Voice, Speech and Hearing Disorders, Center for Clinical Neurosciences, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Till FlügelDepartment of Voice, Speech and Hearing Disorders, Center for Clinical Neurosciences, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Ute HiddingDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Carsten BuhmannDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Daniel WeissCentre of Neurology, Department for Neurodegenerative Diseases and Hertie-Institute for Clinical Brain Research, Tübingen, 72076, Germany.
Christian GerloffDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Wolfgang HamelDepartment of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Christian K E MollDepartment of Neurophysiology and Pathophysiology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Monika Pötter-NergerDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Universität Hamburg · DEHertie Institute for Clinical Brain Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDysphagia is a frequent and highly relevant symptom in Parkinson's disease (PD) due to high associated morbidity and mortality. To compare the effect of simultaneous stimulation of the subthalamic nucleus (STN) and substantia nigra (SNr) with conventional STN-stimulation on swallowing function in Parkinson's disease.

methodsIn this controlled, randomized, double-blind, cross-over clinical trial, 15 PD patients were assessed with DBS switched off (STIM OFF), STN-DBS, STN + SNr-DBS. Patients and 32 age-matched healthy controls were examined clinically and by flexible-endoscopic evaluation of swallowing (FEES) to evaluate the swallowing function. The primary endpoint was the assessment of residues, secondary endpoints were penetration/aspiration, leakage, retained pharyngeal secretions, drooling, and assessments of the patient's self-perception of swallowing on a visual analog scale.

resultsCompared with healthy controls PD patients showed significantly more pharyngeal residues in STIM OFF and both DBS modes. Residues or aspiration events were found in 80% of the patients under STN-stimulation. Simultaneous STN + SNr-stimulation had no additional positive effect on objective dysphagia and self-reported swallowing function compared to STN-DBS.

interpretationSimultaneous STN + SNr-stimulation seems to have no additional beneficial effects on dysphagia when compared with conventional STN-stimulation, but did not deteriorate the swallowing function. If STN + SNr-stimulation is planned to be applied for the improvement of axial symptoms and gait disorders in PD patients, it can be considered safe in terms of dysphagia.

Indexed as

Deep Brain StimulationSubstantia NigraSubthalamic NucleusAgedCross-Over StudiesDeglutition DisordersDouble-Blind MethodFemaleHumansMaleMiddle AgedOutcome Assessment, Health CareParkinson Disease

Identifiers

PMID32267102
PMCPMC7261764
OpenAlexW3014709517

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.